stockrowCardiff Oncology, Inc. (CRDF) vs Fortress Biotech, Inc. (FBIO)
- Cardiff Oncology, Inc. CRDF 0.79 +3.95%
- Fortress Biotech, Inc. FBIO 1.85 +0.54%
Cardiff Oncology, Inc. and Fortress Biotech, Inc. are both Biotechnology companies. Cardiff Oncology, Inc. and Fortress Biotech, Inc. are of similar size ($61.4M and $58.8M). Cardiff Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.6×. Fortress Biotech, Inc. grew revenue faster over the last twelve months: 15.5% against −6.79%. Fortress Biotech, Inc. has the higher net margin (151.0% vs −7,889.0%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 18 metrics below, Fortress Biotech, Inc. leads on 14 and Cardiff Oncology, Inc. on 4.
Valuation
Profitability
| Metric | CRDF | FBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 65.59% | 65.16% |
| Operating margin | (8,320.08%) | (42.61%) | 0.00% |
| Net margin | (7,888.98%) | 150.98% | 0.00% |
| Free cash flow margin | (8,059.45%) | 183.80% | 0.00% |
| Return on equity | (94.14%) | 84.91% | (50.12%) |
| Return on assets | (70.89%) | 43.38% | (45.60%) |
| Return on invested capital | 0.00% | (41.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack